AMC: EBITDA surged, but barely improved per share

In brief

• AMC's cinema business has strengthened markedly, but share issuance has spread much of the improvement across new owners.
• Our calculation shows only a 1.7% improvement in the adjusted operating measure per share; this is an illustrative metric, not shareholder earnings.
• Completion of refinancing, sustained cash generation and further dilution together may determine how much the recovery is worth.

Full cinemas, a smaller slice for shareholders

AMC Entertainment, the cinema company trading on the NYSE under AMC, closed on 28 September at USD 3.29, up 11.90% for the day. This is the last verified complete trading-day price used here; American trading on 29 September is still underway. Hungarian retail investors need to consider dollar exposure and value per share alongside the company's condition. We do not assign an unverified explanation to the daily price jump.

The operating turnaround is tangible. AMC's second-quarter release reports adjusted EBITDA rising from USD 189.5 million to USD 321.4 million year on year. Chief executive Adam Aron described the period as “nothing short of extraordinary”. Net loss was USD 11.4 million. EBITDA is an earnings measure before interest, taxes, depreciation and amortisation, with further company adjustments. It does not deduct financing or investment spending.

For the crucial cross-check, we used weighted average shares in the quarterly filing: these rose from 433.144 million to 722.015 million. Against growth of 69.6% in the company-wide measure, the denominator expanded by 66.7%. Dividing the result by each quarter's average shares gives USD 0.4451, compared with USD 0.4375 previously. The improvement is just 1.7%.

Our calculation rounds only the final results. The chart shows year-on-year changes. This is not official EPS, a dividend or a valuation model: it illustrates how rapidly ownership claims grew relative to operating performance. Average shares measure an accounting period; a later market-capitalisation calculation needs the number actually outstanding at that time.

Our inference: earnings growth outpacing the share count and cash remaining after financing could substantiate the recovery's value for shareholders. This is not a share-price forecast.

Future dilution also deserves attention. The shareholder-meeting filing shows that the equity incentive plan's capacity increased from 25 million to 50 million shares. Additional capacity is an authorisation, not shares already issued. Investors therefore need to follow actual issuance separately from possible future awards.

The narrow passage between cash and debt

Second-quarter free cash flow was USD 190.1 million, whereas the first half generated only USD 15.4 million. Subtracting the quarter from the half gives first-quarter cash flow of minus USD 174.7 million. The strong summer period effectively recovered the earlier outflow. Simply annualising a single good quarter would therefore be misleading.

Source: AMC; our subtraction. Free cash flow is operating cash flow less capital expenditure. Film timing, supplier settlements and working-capital movements can make quarterly figures fluctuate.

A newer positive signal comes from preliminary July–August figures: revenue rose from USD 937.2 million to USD 1334.8 million against the same period a year earlier. Cash at the end of August was USD 832.5 million. These figures are preliminary and unaudited, not a complete third-quarter income statement. Cash balances alone cannot establish free cash flow because borrowing, debt repayments and share sales also affect them.

The planned debt transaction has an aggregate financing amount of USD 3.970 billion. Much of the new funding would replace existing obligations rather than become freely spendable cash. The priced bond totals USD 2 billion, carries an 8.875% coupon and matures in 2031. Our calculation puts the annual coupon on this bond alone at USD 177.5 million.

Closing is expected on 5 October, subject to conditions. Refinancing may buy time, but interest will continue to absorb part of the operating improvement. A better maturity profile does not by itself establish lower debt or cheap funding.

Prospects for Hungarian retail investors

In a favourable scenario, a strong film slate sustains attendance, financing closes and cash generation improves without further substantial share issuance. On a middle path, revenue rises but interest and investment consume the surplus. In an adverse scenario, disappointing releases or financing difficulties could require additional capital. These are conditional scenarios, not numerical probabilities.

Leawood Films is a new opportunity, but the company says its first projects are unlikely before 2027 or 2028. Distributing already financed films may eventually improve auditorium utilisation; it is too early to treat this as promised revenue.

Currency also shapes a Hungarian investor's return. In an illustrative example, a 30% dollar-denominated share gain combined with a 10% weakening of the dollar produces a 17% return in the domestic currency: 1.30 × 0.90 − 1. Conversely, a 30% share decline and a 10% strengthening dollar produce a 23% loss. Conversion spreads, commissions and taxation further change the realised result.

Our dollar-rate and Hungarian-investor explainer provides context; the latest American job-openings figures inform interest-rate expectations. Market co-movement does not establish a certain causal relationship.

What should existing AMC shareholders consider?

Holding: do improving cash generation, manageable interest expense and slowing dilution still support the investment thesis? Cinema sales alone are insufficient; a low nominal share price does not prove cheapness.

Reducing: how large would another sharp decline be in forint terms? If it would threaten financial reserves, or AMC has become overweight, a partial sale is an option to assess. Concentration increases portfolio vulnerability.

Exiting: what would invalidate the original investment rationale? Financing disruption, persistent cash outflows or dilution absorbing operating improvement could be warning signs. Hoping to recover the original purchase price is not an investment case by itself.

Additional purchases should not be justified merely by lowering the average entry price: they increase exposure. Before deciding, investors can write down their tolerable loss, time horizon and review conditions. Commissions, currency conversion and execution risk also matter.

The nearest specific event is the bond tender offer's deadline on 30 September, followed by confirmation that refinancing has closed. In the next complete results, cash flow, interest expense and the share count need to be assessed together. This analysis is information, not a personalised recommendation to buy or sell.